CooperVision Notifies ECPs of Decision to Drop UPP for Biofinity Energys Lenses

By


PLEASANTON, Calif.—CooperVision, a unit of The Cooper Cos. (NYSE:COO), notified ECPs late last week that it was removing its Biofinity Energys contact lens product line from its Unilateral Pricing Policy (UPP) effective immediately. The move is a result of the “well-established [place] in the market” the lenses have achieved, the company said in a letter to eyecare professionals.

In March, CooperVision announced that it was removing three other lens products from its UPP program: MyDay, clariti 1-day and Biofinity XR toric brands. It maintained UPP for Biofinity Energys at that time, as VMail reported.

In a letter from CooperVision’s president, Americas, Jerry Warner, the company noted that “together we’ve made Biofinity Energys a breakthrough success” since the launch in the summer of 2016.” With Biofinity Energys now well-established, “the time has come to remove UPP,” the letter stated.

“This decision was thoughtfully deliberated, much like we take any action that affects our customers and wearers. In that same spirit, we will continue to assess the value of UPP for future products,” Warner’s letter noted.

The moves by contact lens companies to revise UPP programs follow a December 2016 ruling by a U.S. Court of Appeals that allowed a regulation prohibiting the application of UPP for Utah-based retailers to remain in effect, as VMail reported. In response to the Utah regulation, both Alcon and Bausch + Lomb also revised their UPP programs over the past year.

Johnson & Johnson Vision had previously dropped its UPP program, and joined the other contact lens companies to seek an injunction against the Utah regulation.

In last week’s letter, CooperVision’s Warner also noted that the “reaction to this groundbreaking [Biofinity Energys] contact lens has been extremely positive…We have appreciated your comments about the performance of the lens, and hearing how thousands of digital device users have shared your enthusiasm.”